SGEN vs XGN
SGEN (SGEN) versus Exagen Inc (XGN) — a side-by-side from cached financials, not a winner call.
SGEN (SGEN) common stock.
Exagen Inc (XGN) is a diagnostics & research company listed on US.
SGEN does not have a complete income-statement cache yet.
Latest reported XGN revenue for 2026-06-30 was $37.2M. Net income was -$7.2M. XGN currently screens at market cap $154.1M.
XGN currently screens at market cap $154.1M.
Not investment advice. Open the SGEN and XGN stock pages for the full models.
Not investment advice.